Is inflammatory bowel disease a risk factor for early atherosclerosis?

Angiology

Volumn 61, Issue 2, 2010, Pages 198-204

  Dagli, Necati ^a   Poyrazoglu, Orhan K ^a   Ferda Dagli, A ^a   Sahbaz, Fatih ^a   Karaca, Ilgin ^a   Ali Kobat, M ^a   Bahcecioglu, Ibrahim H ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

Atherosclerosis; Homocysteine; Inflammation; Inflammatory bowel disease; Insulin resistance; Intima media thickness

Indexed keywords

C REACTIVE PROTEIN; HOMOCYSTEINE;

ADULT; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENTERITIS; FEMALE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MALE; PREDICTION; RISK FACTOR;

ADOLESCENT; ADULT; AGE OF ONSET; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CAROTID ARTERIES; CAROTID ARTERY DISEASES; COMORBIDITY; ELASTICITY; FEMALE; HOMOCYSTEINE; HUMANS; INFLAMMATORY BOWEL DISEASES; INSULIN RESISTANCE; MALE; TUNICA INTIMA; YOUNG ADULT;

EID: 76649112398     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319709333869     Document Type: Article

References (37)

1. Hatoum OA, Binion DG The vasculature and inflammatory bowel disease: contribution to pathogenesis and clinical pathology. Inflamm Bowel Dis. 2005 ; 11 (3). 304-313.
2. Danesh J., Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004 ; 350 (14). 1387-1397.
3. Papa A., Santoliquido A., Danese S., et al. Increased carotid intima-media thickness in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2005 ; 22 (9). 839-846.
4. Danese S., Sgambato A., Papa A., et al. Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease. Am J Gastroenterol. 2005 ; 100 (4). 886-895.
5. Bregenzer N., Hartmann A., Strauch U., Schölmerich J., Andus T., Bollheimer LC Increased insulin resistance and beta cell activity in patients with Crohn's disease. Inflamm Bowel Dis. 2006 ; 12 (1). 53-56.
6. Van Doornum S., McColl G., Wicks IP Accelerated atherosclerosis. An extraarticular feature of rheumatoid arthritis ? Arthritis Rheum. 2002 ; 46 (4). 862-873.
7. Roman MJ, Shanker B-A., Davis A., et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003 ; 349 (25). 2399-2406.
8. Gazi IF, Boumpas DT, Mikhailidis DP, Ganotakis ES Clustering of cardiovascular risk factors in rheumatoid arthritis: the rationale for using statins. Clin Exp Rheumatol. 2007 ; 25 (1). 102-111.
9. Touboul PJ Clinical impact of intima media measurement. Eur J Ultrasound. 2002 ; 16 (1-2). 105-113.
10. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999 ; 340 (1). 14-22.
11. Roman MJ, Devereux RB, Schwartz JE, et al. Arterial stiffness in chronic inflammatory diseases. Hypertension. 2005 ; 46 (1). 194-199.
12. Lentz SR Mechanisms of homocysteine-induced atherothrombosis. J Thromb Haemost. 2005 ; 3 (8). 1646-1654.
13. Maharshak N., Arbel Y., Bornstein NM, et al. Inflammatory bowel disease is not associated with increased intimal media thickening. Am J Gastroenterol. 2007 ; 102 (5). 1050-1055.
14. Willinek WA, Ludwing M., Lennarz M., Höller T., Stumpe KO High-normal serum homocysteine concentrations are associated with an increased risk of early atherosclerotic carotid artery wall lesions in healthy subjects. J Hypertens. 2000 ; 18 (4). 425-430.
15. Bland JM, Altman DG Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986 ; 1 (8476). 307-310.
16. Peterson LN, Jensen RE, Parnell R. Mechanical properties of arteries in vivo. Circ Res. 1960 ; 8: 622-639.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985 ; 28 (7). 412-419.
18. Karlinger K., Gyorke T., Mako E., Mester A., Tarján Z. The epidemiology and the pathogenesis of inflammatory bowel disease. Eur J Radiol. 2000 ; 35 (3). 154-167. (Pubitemid 30734686)
19. Yu Y., Sitaraman S., Gewirtz AT Intestinal epithelial cell regulation of mucosal inflammation. Immunol Res. 2004 ; 29 (1-3). 55-68.
20. Touboul PJ, Hennerici MG, Meairs S., et al. Mannheim intima-media thickness consensus. Cerebrovasc Dis. 2004 ; 18 (4). 346-349.
21. Papa A., Danese S., Urgesi R., et al. Early atherosclerosis in patients with inflammatory bowel disease. Eur Rev Med Pharmacol Sci. 2006 ; 10 (1). 7-11. (Pubitemid 43299603)
22. Laurent S., Boutouyrie P., Asmar R., et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001 ; 37 (5). 1236-1241.
23. Haverkate F., Thompson SG, Pyke SD, Gallimore JR, Pepys MB Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet. 1997 ; 349 (9050). 426-462.
24. Hu G., Qiao Q., Tuomilehto J., Eliasson M., Feskens EJ, Pyörälä K. DECODE Insulin Study Group Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies. Diabetologia. 2004 ; 47 (7). 1245-1256.
25. Enas A., Garg A., Davidson MA, Nair VM, Huet BA, Yusuf S. Coronary heart disease and its risk factors in first generation immigrant Asian Indians to the United State of America. Indian Heart J. 1996 ; 48 (4). 343-353.
26. Rantala AO, Paivansalo M., Kauma H., et al. Hyperinsulinemia and carotid atherosclerosis in hypertensive and control subjects. Diabetes Care. 1998 ; 21 (7). 1188-1193.
27. Frayn KN Insulin resistance and lipid metabolism. Curr Opin Lipidol. 1993 ; 4 (3). 197-204.
28. Howard G., O'Leary DH, Zaccaro D., et al. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation. 1996 ; 93 (10). 1777-1779 ; 1809-1819.
29. Jhamb R., Gaiha M., Chakravarti A., Daga MK Insulin resistance/ hyperinsulinemia as a risk factor for common carotid artery intima media thickness in essential hypertension. J Indian Acad Clin Med. 2005 ; 6 (2). 122-128.
30. Grundy SM, Howard B., Smith S. Jr, Eckel R., Redberg R., Bonow RO Prevention Conference, VI: Diabetes and cardiovascular disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation. 2002 ; 105 (18). 2231-2239.
31. Capristo E., Mingrone G., Addolorato G., Greco AV, Gasbarrini G. Glucose metabolism and insulin sensitivity in inactive inflammatory bowel disease. Aliment Pharmacol Ther. 1999 ; 13 (2). 209-217.
32. Danese S., Papa A., Saibeni S., Repici A., Malesci A., Vecchi M. Inflammation and coagulation in inflammatory bowel disease: the clot thickens. Am J Gastroenterol. 2007 ; 102 (1). 174-186. (Pubitemid 46072059)
33. van Wersch JWJ, Houben P., Rijken J. Platelet count, platelet function, coagulation activity and fibrinolysis in the acute phase of inflammatory bowel disease. J Clin Chem Clin Biochem. 1990 ; 28 (8). 513-517.
34. Kocaman O., Sahin T., Aygun C., Senturk O., Hulagu S. Endothelial dysfunction in patients with ulcerative colitis. Inflamm Bowel Dis. 2006 ; 12 (3). 166-171.
35. De Leeuw K., Kallenberg C., Bijl M. Accelerated atherosclerosis in patients with systemic autoimmune diseases. Ann N Y Acad Sci. 2005 ; 1051: 362-371. (Pubitemid 41362766)
36. Schroecksnadel K., Frick B., Wirleitner B., Winkler C., Schennach H., Fuchs D. Moderate hyperhomocysteinemia and immune activation. Curr Pharm Biotechnol. 2004 ; 5 (1). 107-118.
37. Lazzerini PE, Capecchi PL, Selvi E., et al. Hyperhomocysteinemia, inflammation and autoimmunity. Autoimmunity Rev. 2007 ; 6 (7). 503-509.